Please enable JS

Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease

Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease

Publication ID: 
GBI0418002
Publication Date: 
April 01, 2018
Pages: 
77
Publisher: 
GBI Research
Region: 
$6,995.00
Please choose the suitable license type from above. More details are at given under tab "Report License Types" below.
Custom Market Research Reports
Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.